For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.
Regulatory context
Regulatory context; not efficacy evidence
No matched trial or lot-level equivalence assessment of this exact preparation was verified.
Reported findings. Background context only. Matched evidence for the exact marketed formulation is not established by this reference.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. No broad hormonal, mitochondrial or longevity efficacy conclusion is established here.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.
Human trial
Purified shilajit: placebo-controlled hormone study (2016)
Healthy men aged 45–55 studied for 90 days.
Reported findings. A randomized placebo-controlled study reported increases in total/free testosterone and DHEAS with a purified preparation.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Hormone biomarkers, not longevity or fitness outcomes. Purification and composition may differ from the marketed preparation.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.
Clinical observation
Processed shilajit: observational infertility study (2010)
35 men with oligospermia enrolled; 28 completed 90 days.
Reported findings. An uncontrolled report described improved semen measures and testosterone from baseline.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. No control group; attrition, no live-birth outcome and no verified equivalence to commercial stock.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.
Human trial
The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels.
63 recreationally active young men; eight-week blinded placebo-controlled study.
Reported findings. Higher-exposure preparation reduced fatigue-related strength loss in the upper baseline-strength subgroup.
Nonresponse. Lower-exposure versus placebo comparison was null. Subgroup signal is not universal strength improvement.
Harms. No adverse events reported during eight weeks; longer safety remains unknown.
Limits. Subgroup and preparation-specific result; not proof of tissue repair. Source exposure comparisons are descriptive, not dose guidance.
Preparation: PrimaVie purified shilajit; unpurified or other commercial preparations not assumed equivalent. Route: oral
Read original source ↗Editorial review 2026-10-09. Clinician review pending.